More Nova Eye Medical Ltd news
Nova Eye Medical LtdASX: EYE

2RT Post LEAD Review Shows Improved Treatment Benefits

Mar 4, 2021 at 9:53 PM EST · Issued by Nova Eye Medical Ltd

Filed with ASX · Mar 4, 2021 at 9:53 PM EST

On 6ix: 6ix.com/news/2rt-post-lead-review-shows-improved-treatment-benefits

Watch Nova Eye Medical's latest call↗Nova Eye Medical (ASX:EYE) Q4 2026 Earnings Call · Replay · Aug 3Read the transcript of Nova Eye Medical (ASX:EYE) Q4 2026 Earnings Call↗

Nova Eye Medical Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Nova Eye Medical Ltd on 6ix

Earlier from Nova Eye Medical

  • Clinical trial to Assess Efficacy and Safety of i TrackMar 1, 2021
  • Investor presentation Half year Results 31 December 2020Feb 24, 2021
  • Half Year Results DiscussionFeb 24, 2021
  • Sales UpdateNov 25, 2020
  • Establishment of AlpaRETOct 25, 2020

Later from Nova Eye Medical

  • First Patient enrolled in MAGIC Clinical TrialApr 29, 2021
  • FY21 Trading UpdateJul 20, 2021
  • FY21 Investor presentationAug 18, 2021
  • Full Year Results FY21Aug 18, 2021
  • FY21 Appendix 4E and Annual ReportAug 18, 2021
All Nova Eye Medical news releases↗

Follow Nova Eye Medical into a list and get an email when it puts out news.

Follow Nova Eye Medical
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer